These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 27230847

  • 1. [The Importance of teriparatide in the treatment of osteoporosis].
    Yamauchi M.
    Clin Calcium; 2016 Jun; 26(6):905-13. PubMed ID: 27230847
    [Abstract] [Full Text] [Related]

  • 2. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
    Bhattacharyya S, Pal S, Chattopadhyay N.
    Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
    [Abstract] [Full Text] [Related]

  • 3. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
    Anastasilakis AD, Polyzos SA, Avramidis A, Papatheodorou A, Terpos E.
    Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
    [Abstract] [Full Text] [Related]

  • 4. Osteoanabolic and dual action drugs.
    Tabacco G, Bilezikian JP.
    Br J Clin Pharmacol; 2019 Jun; 85(6):1084-1094. PubMed ID: 30218587
    [Abstract] [Full Text] [Related]

  • 5. [Daily subcutaneous injection of teriparatide : the progress and current issues].
    Yano S, Sugimoto T.
    Clin Calcium; 2014 Jan; 24(1):35-43. PubMed ID: 24369278
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-Term Effects of Teriparatide Followed by Antiresorptive Therapy on Clinical Outcomes in Patients with Severe Spinal Osteoporosis.
    Oswald AJ, Berg K, Ralston SH, Riches PL.
    Calcif Tissue Int; 2019 Aug; 105(2):148-155. PubMed ID: 31115640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anabolic and antiresorptive therapy for osteoporosis: combination and sequential approaches.
    Cosman F.
    Curr Osteoporos Rep; 2014 Dec; 12(4):385-95. PubMed ID: 25341476
    [Abstract] [Full Text] [Related]

  • 10. Effect of Time of Administration of Teriparatide on Bone Mineral Density in Glucocorticoid-Induced Osteoporosis.
    Mastaglia SR.
    J Clin Densitom; 2017 Dec; 20(4):513-515. PubMed ID: 28579148
    [Abstract] [Full Text] [Related]

  • 11. New therapeutic targets for osteoporosis.
    Anagnostis P, Gkekas NK, Potoupnis M, Kenanidis E, Tsiridis E, Goulis DG.
    Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anabolic agents: what is beyond osteoporosis?
    Liu Y, Levack AE, Marty E, Or O, Samuels BP, Redko M, Lane JM.
    Osteoporos Int; 2018 May; 29(5):1009-1022. PubMed ID: 29627891
    [Abstract] [Full Text] [Related]

  • 16. Indications to teriparatide treatment in patients with osteoporosis.
    Rizzoli R, Kraenzlin M, Krieg MA, Mellinghoff HU, Lamy O, Lippuner K.
    Swiss Med Wkly; 2011 May; 141():w13297. PubMed ID: 22057669
    [Abstract] [Full Text] [Related]

  • 17. [Once-weekly teriparatide treatment on osteoporosis].
    Nakano T.
    Clin Calcium; 2014 Jan; 24(1):100-5. PubMed ID: 24369286
    [Abstract] [Full Text] [Related]

  • 18. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT, Christensen PM, Ejersted C, Langdahl BL.
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [Abstract] [Full Text] [Related]

  • 19. Anabolic skeletal therapy for osteoporosis.
    Girotra M, Rubin MR, Bilezikian JP.
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
    [Abstract] [Full Text] [Related]

  • 20. Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis.
    Sugiura T, Kashii M, Matsuo Y, Morimoto T, Honda H, Kaito T, Iwasaki M, Yoshikawa H.
    Spine J; 2015 Feb 01; 15(2):298-306. PubMed ID: 25110274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.